AMA Update

AMA CXO Todd Unger discusses COVID data reporting changes and strengthening public health infrastructure with Marcus Plescia, MD, MPH, the chief medical officer of the Association of State and Territorial Health Officials (ASTHO) in Atlanta.

AMA CXO Todd Unger reviews COVID-19 case numbers and the legal battle over mask mandates with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the CDC's latest health alert for COVID therapies, as well as the FDA's approval of Remdesivir to treat pediatric coronavirus patients (kids 12 and younger). More information on the CDC's health alert: https://emergency.cdc.g...

AMA CXO Todd Unger reviews changes to the national mask mandate with AMA Director of Science, Medicine and Public Health Andrea Garcia, including which airlines no longer require masks and the cities still enforcing mask mandates on public transit. Also covering the emerging subvariants BA.2.12 and BA.2.12.1, a new COVID breath test, and why Americans over 60 should get a second booster shot.

AMA CXO Todd Unger is joined by Tom Frieden, MD, MPH, former director of the CDC and president and CEO of Resolve to Save Lives in New York to discuss how we can use lessons from the past two years to strengthen our public health system and pandemic response.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering updates from FDA’s vaccine advisory committee meeting regarding a revised version of the COVID vaccine for fall, the FDA suspending use of a monoclonal antibody drug by GlaxoSmithKline known as sotro...

AMA CXO Todd Unger discusses the latest research on long COVID with Akiko Iwasaki, PhD, the Sterling Professor of Immunobiology at Yale University and a principal investigator at the Howard Hughes Medical Institute.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the spread of the BA2 variant, Medicare paying for at-home COVID tests, as well as the latest from the FDA and CDC regarding who may get a second COVID booster shot.

For more resources and access to “A Physician Guide to Keeping Your Practice Open During the Ongoing COVID-19 Pandemic,” visit: ama-assn.org/KeepPracticeOpenGuide

AMA CXO Todd Unger reflects on #SaveYourVisionMonth with David Aizuss, MD, an ophthalmologist in Los Angeles and an AMA trustee, who shares what physicians want you to know about how the pandemic may be affecting your eye health and the importance of regular eye care from a physician.

AMA CXO Todd Unger reviews COVID-19 trending topics and news related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA's authorization of a second booster shot, as well as changes in COVID treatments and therapies. Additionally, uninsured patients may have to pay high prices out-of-pocket for COVID tests and vaccinatio...

AMA CXO Todd Unger reviews COVID-19 news and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering what we know about the BA.2 Omicron subvariant, if a new surge is coming soon, the latest on booster shots and changing data collection on the pandemic.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering state-wide mandates lifting for masks in school, and the latest developments on when a COVID vaccine will be available for kids under 5.

AMA CXO Todd Unger talks with AMA President Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares five actions we can take now to fix our ailing health care system and rebuild trust.

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the government's newly released COVID response strategy and how it will take the nation out of crisis mode, the CDC's scaled back contact tracing efforts and the U.S. Surgeon General's renewed push to f...

AMA CXO Todd Unger talks with Stephen Parodi, MD, the executive vice president of external affairs, communications and brand at The Permanente Federation, and associate executive director for The Permanente Medical Group in Oakland, Calif., about pandemic vs. endemic and what that shift will mean for our COVID-19 response.

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering new data from CDC studies, understanding community risk and finding your local COVID-19 Community Level, as well as positive long-lasting effects of COVID booster shots. Access the Centers for Disease C...

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on coronavirus treatments, including Merk's COVID pill, as well as research outlining the positive effects of getting vaccinated during pregnancy.

In part three of this three-part series, Aimee Hodowanec, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what physicians need to know about Molnupiravir as treatment for COVID-19.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA's pivot to wait for more data on vaccines for kids under 5, and what new data from the CDC tells us about booster shots.

In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.

AMA CXO Todd Unger dives into new developments from ACIP's emergency meeting on Feb. 4 with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed. Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Eva...

AMA CXO Todd Unger is joined by the AMA’s president, Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares new information and big takeaways about therapeutics for COVID-19 after his recent conversation with three physician leaders from the FDA.

AMA CXO Todd Unger talks with David Rubin, MD, director of PolicyLab at Children’s Hospital of Philadelphia and a professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, about his team's nationally recognized COVID-19 forecasting model and how it informs new guidance for K-12 educational settings aimed at keeping kids in school.